Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
The HIV protease inhibitor Nelfinavir down-regulates p70S6K/S6 signaling, induce autophagy and apoptosis in thyroid cancer cells. MedStar authors:
- Boyle, Lisa
- Burman, Kenneth D
- Felger, Erin
- Kushchayeva, Yevgeniya
Year: 2013
All authors: - Kushchayeva Y, Costello J, Felger E, Boyle L, Burman K, Vasko V
|
|
|
19.
|
Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer. MedStar authors:
- Burman, Kenneth D
- Klubo-Gwiezdzinska, Joanna
- Mete, Mihriye
- Wartofsky, Leonard
Year: 2013
All authors: - Klubo-Gwiezdzinska J, Costello J, Patel A, Bauer AJ, Jensen KE, Mete M, Burman K, Wartofsky L
|
|
|
20.
|
|
|
|
21.
|
|
|
|
22.
|
Identification of molecular targets in distant metastases of patients with thyroid cancer. MedStar authors:
- Bikas, Athanasios
- Burman, Kenneth D
- Larin, Olexandre
- Patel, Aneeta
- Wartofsky, Leonard
Year: 2019
Department:
- Medicine/Endocrinology
- MedStar Georgetown University Hospital Residents
All authors: - Bikas A, Jensen K, Patel A, Larin O, Wartofsky L, Burman K, Vasko V.
|
|
|
23.
|
|
|
|
24.
|
|
|
|
25.
|
|
|
|
26.
|
How should one measure and how low should the urinary iodine excretion be prior to radioiodine imaging and/or therapy in patients with differentiated thyroid cancer? An educational exhibit MedStar authors:
- Bethancourt, E
- Burman, Kenneth D
- Moreau, Shari
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bethancourt E, Moreau S, Guan H, Burman K, Wartofsky L, Van Nostrand D
|
|
|
27.
|
|
|
|
28.
|
|
|
|
29.
|
|
|
|
30.
|
|
|
|
31.
|
The utility of 18F sodium fluoride PET bone scans in patients suspected of metastatic skeletal disease secondary to differentiated thyroid cancer MedStar authors:
- Bethancourt, E
- Burman, Kenneth D
- Garcia, Carlos
- Van Nostrand, Douglas
- Wartofsky, Leonard
- Wexler, Jason
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Garcia CA, Van Nostrand D, Wexler JA, Bethancourt E, Burman k, Wartofsky l
|
|
|
32.
|
A comprehensive meta-analysis of endocrine immune-related adverse events of immune checkpoint inhibitors and outcomes in head and neck cancer and lung cancer. MedStar authors:
- Burman, Kenneth D
- Fernandez, Stephen P
- Gomes Lima, Christiane J
- King, Fred
- Veytsman, Irina
Year: 2019
Department:
- Library
- Medicine/Endocrinology
All authors: - Gomes Lima C, Kwagyan J, King F, Fernandez S, Burman K, Veytsman I.
|
|
|
33.
|
|
|
|
34.
|
Effects of dosimetry-guided 131I therapy for metastatic differentiated thyroid cancer on complete blood counts MedStar authors:
- Bikas, A
- Burman, Kenneth D
- Desale, Sameer
- Mete, Mihriye
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bikas A, Burman K, Desale S., Mete M, Wartofsky L, Van Nostrand D
|
|
|
35.
|
Poor compliance for continuous sialogogues in patient-reported surveys. MedStar authors:
- Burman, Kenneth D
- Kulkarni, Kanchan P
- Moreau, Shari
- Van Nostrand, Douglas
- Wartofsky, Leonard
- Wu, Di
Year: 2018
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors:
- Burman K
- Kharazi P
- Khorjekar G
- Kulkarni K
- Moreau S
- Van Nostrand D.
- Wartofsky L
- Wu D
|
|
|
36.
|
The frequency and content of documents issued for patients' 131I therapies for security agents: the final report of a national survey MedStar authors:
- Bethancourt, E
- Bikas, A
- Burman, Kenneth D
- Orquiza, Michael H
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman k, Wartofsky l
|
|
|
37.
|
The public sites and frequency of detection of patients treated with 131I and the security management of those patients: the final report of a national survey MedStar authors:
- Bethancourt, E
- Bikas, A
- Burman, Kenneth D
- Orquiza, Michael H
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman k, Wartofsky l
|
|
|
38.
|
Radioiodine dosimetry practices in the united states for differentiated thyroid cancer: preliminary report. MedStar authors:
- Burman, Kenneth D
- Gomes Lima, Christiane J
- Van Nostrand, Douglas
- Wartofsky, Leonard
- Wu, Di
- Ylli, Dorina
Year: 2019
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
- Pathology
All authors: - Wu D...[Ylli D, Gomes-Lima C, Burman K, Wartofsky L, Van Nostrand], et al.
|
|
|
39.
|
Assessment of serial comprehensive metabolic Panel ats following dosimetry-guided 131I treatment for metastatic differentiated thyroid cancer MedStar authors:
- Bikas, Athanasios
- Boulougoura, Afroditi
- Burman, Kenneth D
- Mirza, Faryal
- Vachhani, Shivangi
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2016
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bikas A, Boulougoura A, Mirza F, Vachhani S, Wartofsky L, Van Nostrand D, Burman K
|
|
|
40.
|
New use for an old isotope. MedStar authors:
- Burman, Kenneth D
- Gomes Lima, Christiane J
- Van Nostrand, Douglas
- Wartofsky, Leonard
- Wu, Di
- Ylli, Dorina
Year: 2018
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors:
- Burman K
- Gomes Lima C
- Van Nostrand D.
- Wartofsky L
- Wu D
- Ylli D
|
|
|
41.
|
|
|
|
42.
|
Assessment of serial complete blood counts following dosimetry-guided 131I treatment for metastatic differentiated thyroid cancer MedStar authors:
- Bikas, A
- Boyle, Lisa M
- Burman, Kenneth D
- Desale, Sameer
- Mete, Mihriye
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bikas A, Burman K, Desale S, Mete M, Boyle L, Wartofsky L, Van Nostrand D
|
|
|
43.
|
|
|
|
44.
|
Characterization of sialoadenitis after administration of continous sialogogues during the day and night After 131 I therapy. MedStar authors:
- Acio, Elmo
- Burman, Kenneth D
- Garcia, Carlos
- Khorjekar, Gauri
- Kulkarni, Kanchan
- Orquiza, Michael D
- Schneider, Mark
- Wartofsky, Leonard
Year: 2013
Department:
- Department of Medicine/Endocrinology
- Department of Medicine/Nuclear Medicine
All authors: - Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L
|
|
|
45.
|
|
|
|
46.
|
Survival rate in differentiated thyroid cancer patients with bone metastases. MedStar authors:
- Atkins, Francis
- Burman, Kenneth D
- Khorjekar, Gauri R
- Kulkarni, Kanchan
- Moreau, Shari
- Orquiza, Michael H
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2014
Department:
- Medicine/Endocrinology
- Medicine/General Internal Medicine
- Medicine/Nuclear Medicine
All authors: - Orquiza M, Van Nostrand D, Khorjekar G, Moreau S, Atkins F, Kulkarni K, Burman KD, Wartofsky L
|
|
|
47.
|
|
|
|
48.
|
Altered taste after 131I therapy: the frequency, time of onset, severity, and duration MedStar authors:
- Acio, Elmo
- Burman, Kenneth D
- Garcia, Carlos
- Khorjekar, Gauri R
- Kulkarni, Kanchan
- Orquiza, Michael H
- Schneider, M
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2014
Department:
- Medicine/Endocrinology
- Medicine/General Internal Medicine
- Medicine/Nuclear Medicine
All authors: - Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L,Van Nostrand D
|
|
|
49.
|
Epiphora and xerophthalmia after 131I therapy: the frequency, time of onset, severity, and duration. MedStar authors:
- Acio, Elmo
- Burman, Kenneth D
- Garcia, Carlos
- Khorjekar, Gauri R
- Kulkarni, Kanchan
- Orquiza, Michael H
- Schneider, M
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2014
Department:
- Medicine/Endocrinology
- Medicine/General Internal Medicine
- Medicine/Nuclear Medicine
All authors: - Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D
|
|
|
50.
|
|
|
|
51.
|
Brain metastases from differentiated thyroid carcinoma: current therapies and outcomes. MedStar authors:
- Burman, Kenneth D
- Deeb, Hala
- Gomes-Lima, Christiane J
- Hritani, Rama
- Mete, Mihriye
- Punukollu, Sree
- Rao, Sarika
- Van Nostrand, Douglas
- Wu, Di
- Zeymo, Alexander
Year: 2017
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors:
- Burman K
- Deeb H
- Gomes-Lima C
- Hritani R
- Jonklaas J
- Mete M
- Punukollu S
- Rao S
- Van Nostrand D
- Wu D
- Zeymo A
|
|
|
52.
|
Prevalence and survival analysis of patients with brain metastases from differentiated thyroid carcinoma in MedStar institutions. MedStar authors:
- Aulisi, Edward
- Burman, Kenneth D
- Deeb, Hala
- Gomes Lima, Christiane J
- Hritani, Rama
- Mete, Mihriye
- Punukollu, Sree
- Rao, Sarika
- Van Nostrand, Douglas
- Wu, Di
- Zeymo, Alexander
Year: 2018
Department:
- Medicine/Endocrinology
- Surgery/Neurosurgery
All authors:
- Aulisi E
- Burman K.
- Deeb H
- Gomes-Lima C
- Hritani R
- Jonklaas J
- Mete M
- Punukollu S
- Rao S
- Van Nostrand D
- Wu D
- Zeymo A
|
|
|
53.
|
Do molecular profiles of primary versus metastatic radioiodine refractory differentiated thyroid cancer differ? MedStar authors:
- Bikas, Athanasios
- Burman, Kenneth D
- Chittimoju, Sanjita
- Gomes Lima, Christiane J
- Jonklaas, Jacqueline
- Lee, Wen
- Parikh, Tanvi
- Rao, Sarika
- Shobab, Leila
- Wartofsky, Leonard
- Wexler, Jason A
- Wu, Di
- Ylli, Dorina
Year: 2019
Department:
- Medicine/Endocrinology
- Pathology
All authors: - Gomes-Lima C, Shobab L, Wu D, Yll D, Bikas A, Avadhanula S, Parikh T, Chittimoju S, McCoy M, Rao S, Feldman R, Lee W, Wexler J, Jonklaas J, Wartofsky L, Burman K.
|
